Thimerosal
Research News and Information

Sunday, November 22, 2009

Breastfeeding is an essential complement to vaccination.

30 Jul 2009 AIM: This article explores the role of breastfeeding in different aspects of vaccination in the first 6 months when infants are still developing: (1) pain management; (2) immunomodulation of infants' vaccine responses; (3) metabolism of thimerosal. ... Read more...

Autism and vaccination-the current evidence.

29 Jun 2009 PURPOSE: The purpose of this article is to review relevant background literature regarding the evidence linking thimerosal-containing vaccine and the measles, mumps, and rubella vaccine to autism. CONCLUSIONS: Rigorous scientific studies have not ... Read more...

Mercury levels in premature and low birth weight newborn infants after receipt of thimerosal-containing vaccines.

24 Jun 2009 OBJECTIVE: We conducted a population-based pharmacokinetic study to assess blood levels and elimination of mercury after vaccination of premature infants born at > or =32 and <37 weeks of gestation and with birth weight > or =2000 but <3000 g. STUDY ... Read more...

Latest indexed articles for 'Thimerosal'

These are the very latest articles for this heading:

• Breastfeeding is an essential complement to vaccination. 30 Jul 2009
• Autism and vaccination-the current evidence. 29 Jun 2009
• Mercury levels in premature and low birth weight newborn infants after receipt of thimerosal-containing vaccines. 24 Jun 2009
• Litigation, regulation, and education--protecting the public's health through childhood immunization. 9 Jun 2009
• When vaccine injury claims go to court. 9 Jun 2009
• Breast-feeding does a lot more than reduce pain in vaccinated neonates and infants. 30 May 2009
• Cutaneous allergy testing in patients suspected of an allergic reaction to eye medication. 13 May 2009
• Re: "Determinants of the incidence of childhood asthma: a two-stage case-control study". 9 May 2009
• Calcium and calmodulin regulate mercury-induced phospholipase D activation in vascular endothelial cells. 29 Apr 2009
• Method of oocyte activation affects cloning efficiency in pigs. 29 Apr 2009
• Expression of metallothionein mRNAs on mouse cerebellum microglia cells by thimerosal and its metabolites. 17 Apr 2009
• Comparative toxicity of preservatives on immortalized corneal and conjunctival epithelial cells. 30 Mar 2009
• Cellular and mitochondrial glutathione redox imbalance in lymphoblastoid cells derived from children with autism. 21 Mar 2009
• Neonate exposure to thimerosal mercury from hepatitis B vaccines. 10 Mar 2009
• Molecular structures of protonated and mercurated derivatives of thimerosal. 9 Mar 2009
• Comparing fish-mercury exposed Amazonian children: Should not we consider thimerosal-preserved vaccines? 11 Feb 2009
• Are toxic biometals destroying your children's future? 9 Feb 2009
• The rise in autism and the mercury myth. 30 Jan 2009
• Neuropsychological performance 10 years after immunization in infancy with thimerosal-containing vaccines. 30 Jan 2009
• Presence of thimerosal in vaccines. 22 Jan 2009

See a longer list of these articles.

Technical information about 'Thimerosal'

Definition: An ethylmercury-sulfidobenzoate that has been used as a preservative in VACCINES; ANTIVENINS; and OINTMENTS. It was formerly used as a topical antiseptic. It degrades to ethylmercury and thiosalicylate.

Chemical name: Mercurate(1-), ethyl(2-mercaptobenzoato(2-)-O,S)-, sodium

Registry Number: 54-64-8

Descriptor UI: D013849

Alternative terms: Thimerosal; Sodium Ethylmercurithiosalicylate; Ethylmercurithiosalicylate, Sodium; Thiomersalate; Mercurothiolate; Thiomersal; Vitaseptol; Novartis Brand of Thimerosal; Merthiolate;

Allowable Qualifiers: administration & dosage; adverse effects; analogs & derivatives; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Pharmacological Action: Preservatives, Pharmaceutical;

Tree Number: D02.691.750.100.347.850;

History Note: 91(75); was see under ETHYLMERCURY COMPOUNDS 1980-90; was see under ETHYL MERCURY COMPOUNDS 1975-79